| 1 |
33825892 | MEVITEM-a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation. | 2021 Nov 2 |
1 |
| 2 |
32622951 | Cyclopamine sensitizes glioblastoma cells to temozolomide treatment through Sonic hedgehog pathway. | 2020 Sep 15 |
2 |
| 3 |
30790292 | Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1α/hedgehog pathway under hypoxia. | 2019 Aug |
2 |
| 4 |
29515801 | Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression. | 2018 Feb 9 |
2 |
| 5 |
28446712 | Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy. | 2017 Apr |
4 |
| 6 |
28477008 | Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation. | 2017 Jun 27 |
2 |
| 7 |
25595896 | Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level. | 2015 Jan 20 |
6 |
| 8 |
27158638 | Temozolomide resistance and tumor recurrence: Halting the Hedgehog. | 2015 |
1 |
| 9 |
20957337 | Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. | 2011 Jan-Feb |
3 |